| Stage | DOCN | % of rev | RSI | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $281M | 100.00% | $386M | 100.00% | RSI ×1.37 |
| Gross profit | $155M | 55.00% | $140M | 36.39% | DOCN +18.6pp |
| Operating income | $29M | 10.45% | $43M | 11.05% | RSI +0.6pp |
| Pre-tax income | $27M | 9.65% | $47M | 12.13% | RSI +2.5pp |
| Net income | $35M | 12.60% | $29M | 7.43% | DOCN +5.2pp |
| Stage | DOCN | RSI | Gap · A − B |
|---|---|---|---|
| Revenue | $281M100.00% | $386M100.00% | RSI ×1.37 |
| Gross profit | 55.00%$155M | 36.39%$140M | DOCN +18.6pp |
| Operating income | 10.45%$29M | 11.05%$43M | RSI +0.6pp |
| Pre-tax income | 9.65%$27M | 12.13%$47M | RSI +2.5pp |
| Net income |
| 12.60%$35M |
| 7.43%$29M |
| DOCN +5.2pp |
No shared counterparties.